Literature DB >> 9452359

The expression and modulation of IFN-alpha and IFN-beta in human keratinocytes.

H Fujisawa1, S Kondo, B Wang, G M Shivji, D N Sauder.   

Abstract

In addition to leukocytes and fibroblasts, the classic sources of human interferons (IFN), many other human cells are now known to be capable of producing IFN. Keratinocytes (KC) are abundant in the skin and provide the first line of defense against viruses and other noxious agents. Human KC are a potent source of cytokines and were implicated as forming IFN-like protein(s). We have investigated whether KC form IFN. We found that culture supernatants from unstimulated human KC did not contain detectable amounts of IFN-alpha or IFN-beta. However, those from KC activated with the potent IFN inducer, polyriboinosinic:polriboycytidylic acid (poly rI:rC), had appreciable antiviral activity, which studies with neutralizing sera showed to be caused by IFN-beta. In ELISA tests, we detected IFN-beta protein in the supernatants but not IFN-alpha protein. Nevertheless, reverse transcription PCR showed that both IFN-alpha and IFN-beta mRNA were upregulated in poly rI:rC-treated KC. The levels of these mRNA were also increased in KC exposed to ultraviolet B (UVB) irradiation, interleukin-1alpha (IL-1alpha), tumor necrosis factor-alpha (TNF-alpha), or lipopolysaccharide (LPS). These results show that IFN-beta is among the cytokines secreted from human KC and, together with IFN-alpha, may have a role in host defense mechanisms in the skin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9452359     DOI: 10.1089/jir.1997.17.721

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  9 in total

1.  Hypothesis: Wound-induced TLR3 activation stimulates endogenous retinoic acid synthesis and signalling during regeneration.

Authors:  Dongwon Kim; Luis A Garza
Journal:  Exp Dermatol       Date:  2019-04       Impact factor: 3.960

2.  Interferon-Gamma Enhances TLR3 Expression and Anti-Viral Activity in Keratinocytes.

Authors:  A I Kajita; Shin Morizane; Tetsuya Takiguchi; Takenobu Yamamoto; Masao Yamada; Keiji Iwatsuki
Journal:  J Invest Dermatol       Date:  2015-03-30       Impact factor: 8.551

3.  Keratinocyte Response to Infection with Sporothrix schenckii.

Authors:  Araceli Paredes-Rojas; Alejandro Palma-Ramos; Laura Estela Castrillón-Rivera; Felipe Mendoza-Pérez; María Del Carmen Navarro-González; Roberto Arenas-Guzmán; Jorge Ismael Castañeda-Sánchez; Julieta Luna-Herrera
Journal:  J Fungi (Basel)       Date:  2022-04-23

Review 4.  Type I interferon in organ-targeted autoimmune and inflammatory diseases.

Authors:  Mary K Crow
Journal:  Arthritis Res Ther       Date:  2010-08-25       Impact factor: 5.156

Review 5.  Molecular genetic analysis of orf virus: a poxvirus that has adapted to skin.

Authors:  Stephen B Fleming; Lyn M Wise; Andrew A Mercer
Journal:  Viruses       Date:  2015-03-23       Impact factor: 5.048

6.  Chicken IFN Kappa: A Novel Cytokine with Antiviral Activities.

Authors:  Diwakar Santhakumar; Munir Iqbal; Venugopal Nair; Muhammad Munir
Journal:  Sci Rep       Date:  2017-06-02       Impact factor: 4.379

7.  La Crosse Virus Infection of Human Keratinocytes Leads to Interferon-Dependent Apoptosis of Bystander Non-Infected Cells In Vitro.

Authors:  Maria A Cruz; Griffith D Parks
Journal:  Viruses       Date:  2020-02-25       Impact factor: 5.048

8.  IFN-κ is critical for normal wound repair and is decreased in diabetic wounds.

Authors:  Sonya J Wolf; Christopher O Audu; Amrita Joshi; Aaron denDekker; William J Melvin; Frank M Davis; Xianying Xing; Rachael Wasikowski; Lam C Tsoi; Steven L Kunkel; Johann E Gudjonsson; Mary X O'Riordan; J Michelle Kahlenberg; Katherine A Gallagher
Journal:  JCI Insight       Date:  2022-05-09

Review 9.  Cytokinocytes: the diverse contribution of keratinocytes to immune responses in skin.

Authors:  Yanyun Jiang; Lam C Tsoi; Allison C Billi; Nicole L Ward; Paul W Harms; Chang Zeng; Emanual Maverakis; J Michelle Kahlenberg; Johann E Gudjonsson
Journal:  JCI Insight       Date:  2020-10-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.